Circular HER2 RNA positive triple negative breast cancer is sensitive to Pertuzumab

Circular HER2 RNA positive triple negative breast cancer is sensitive to Pertuzumab

Abstract Background Triple negative breast cancer (TNBC) remains the most challenging breast cancer subtype so far. Specific therapeutic approaches have rarely achieved clinical improvements in treatment of TNBC patients and effective molecular biomarkers are largely unknown. Methods We used paired...

Full description

Bibliographic Details
Main Authors: Jie Li, Maoguang Ma, Xuesong Yang, Maolei Zhang, Jingyan Luo, Huangkai Zhou, Nunu Huang, Feizhe Xiao, Bingquan Lai, Weiming Lv, Nu Zhang
Format: Article
Language:English
Published: BMC 2020-09-01
Series:Molecular Cancer
Subjects:
circRNA
TNBC
Circ-HER2
Pertuzumab
Online Access:http://link.springer.com/article/10.1186/s12943-020-01259-6

Internet

http://link.springer.com/article/10.1186/s12943-020-01259-6

Similar Items